Altered Crossbridge Kinetics in the αMHC 403/+ Mouse Model of Familial Hypertrophic Cardiomyopathy
- 5 March 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 84 (4) , 475-483
- https://doi.org/10.1161/01.res.84.4.475
Abstract
—A mutation in the cardiac β-myosin heavy chain, Arg403Gln (R403Q), causes a severe form of familial hypertrophic cardiomyopathy (FHC) in humans. We used small-amplitude (0.25%) length-perturbation analysis to examine the mechanical properties of skinned left ventricular papillary muscle strips from mouse hearts bearing the R403Q mutation in the α-myosin heavy chain (αMHC403/+). Myofibrillar disarray with variable penetrance occurred in the left ventricular free wall of the αMHC403/+ hearts. In resting strips (pCa 8), dynamic stiffness was ≈40% greater than in wild-type strips, consistent with elevated diastolic stiffness reported for murine hearts with FHC. At pCa 6 (submaximal activation), strip isometric tension was ≈3 times higher than for wild-type strips, whereas at pCa 5 (maximal activation), tension was marginally lower. At submaximal calcium activation the characteristic frequencies of the work-producing (b) and work-absorbing (c) steps of the crossbridge were less in αMHC403/+ strips than in wild-type strips (b=11±1 versus 15±1 Hz; c= 58±3 versus 66±3 Hz; 27°C). At maximal calcium activation, strip oscillatory power was reduced (0.53±0.25 versus 1.03±0.18 mW/mm3; 27°C), which is partly attributable to the reduced frequency b, at which crossbridge work is maximum. The results are consistent with the hypothesis that the R403Q mutation reduces the strong binding affinity of myosin for actin. Myosin heads may accumulate in a preforce state that promotes cooperative activation of the thin filament at submaximal calcium but blunts maximal tension and oscillatory power output at maximal calcium. The calcium-dependent effect of the mutation (whether facilitating or debilitating), together with a variable degree of fibrosis and myofibrillar disorder, may contribute to the diversity of clinical symptoms observed in murine FHC.Keywords
This publication has 28 references indexed in Scilit:
- Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy.Journal of Clinical Investigation, 1998
- Calcium cycling and contractile activation in intact mouse cardiac muscleThe Journal of Physiology, 1998
- Characterization of mutant myosins of Dictyostelium discoideum equivalent to human familial hypertrophic cardiomyopathy mutants. Molecular force level of mutant myosins may have a prognostic implication.Journal of Clinical Investigation, 1997
- Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy.Journal of Clinical Investigation, 1995
- Molecular Genetics of Familial Hypertrophic CardiomyopathyJournal of Molecular and Cellular Cardiology, 1994
- Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy.Journal of Clinical Investigation, 1993
- A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutationPublished by Elsevier ,1990
- Force-velocity-length relations in hypertrophic cardiomyopathy: Evidence of normal or depressed myocardial contractilityThe American Journal of Cardiology, 1983
- Influence of temperature upon contractile activation and isometric force production in mechanically skinned muscle fibers of the frog.The Journal of general physiology, 1982
- Effect of verapamil on left ventricular isovolumic relaxation time and regional left ventricular filling in hypertrophic cardiomyopathyThe American Journal of Cardiology, 1980